Record:   Prev Next
書名 Radiation oncology and radiotherapy. Part A / edited by Ai Sato, Jeffrey Kraynak, Ariel E. Marciscano, Lorenzo Galluzzi
出版項 Cambridge, MA : Academic Press, 2022
國際標準書號 9780323899505
0323899501
book jacket
說明 1 online resource
系列 Methods in cell biology ; v. 172
附註 Print version record
Intro -- Radiation Oncology and Radiotherapy Part A -- Copyright -- Contents -- Contributors -- Radiation therapy: An old dog learning new tricks -- Acknowledgments -- Conflict of interest -- References -- Chapter 1: Cytofluorometric assessment of cell cycle progression in irradiated cells -- 1. Introduction -- 2. Materials -- 2.1. Common disposables -- 2.2. Cells and reagents -- 2.3. Equipment -- 2.4. Software -- 3. Methods -- 3.1. Cell seeding and treatment (see Note 17) -- 3.2. BrdU pulsing -- 3.3. Fixation, permeabilization and DNA denaturation -- 3.4. Staining -- 3.5. Flow cytometry acquisition -- 3.6. Data analysis -- 4. Notes -- 5. Concluding remarks -- Acknowledgments -- Competing interests -- References -- Chapter 2: Cytofluorometric assessment of acute cell death responses driven by radiation therapy -- 1. Introduction -- 2. Materials -- 2.1. Common disposables -- 2.2. Cells and reagents -- 2.3. Equipment -- 2.4. Software -- 3. Methods -- 3.1. Cell culture and treatments (see Note 21) -- 3.2. Sample collection -- 3.3. DiOC6(3)/PI co-staining -- 3.4. FITC-AnnV/PI co-staining -- 3.5. Acquisition -- 3.6. Gating and data analysis -- 4. Notes -- 5. Concluding remarks -- Acknowledgments -- Conflicts of interest -- References -- Chapter 3: Assessment of lipid peroxidation in irradiated cells -- 1. Introduction -- 2. Materials -- 2.1. Disposables -- 2.2. Reagents -- 2.3. Cell lines -- 2.4. Equipment -- 2.5. Software -- 3. Methods -- 3.1. Cell cultures -- 3.2. Cell irradiation -- 3.3. BODIPY 581/591 C11 staining -- 3.4. Flow cytometry -- 3.5. Data analysis -- 3.6. Concluding remarks -- 3.7. Notes -- Acknowledgments -- Disclosures -- References -- Chapter 4: Biochemical, genomic, and epigenomic profiling of isolated cancer cell lines micronuclei -- 1. Introduction -- 2. Materials (see note 1)
2. Material -- 2.1. Disposables -- 2.2. Equipment -- 2.3. Reagents -- 2.4. Biological material -- 3. Method -- 3.1. Cell culture -- 3.2. Compound preparation -- 3.3. Cell seeding and treatment -- 3.4. Image acquisition and analysis -- 3.5. Cell features extraction and data analysis -- 4. Notes -- 5. Concluding remarks -- Acknowledgments -- Conflict of interest -- References -- Chapter 10: RT-PCR-assisted quantification of type I IFN responses in irradiated cancer cells -- 1. Introduction -- 2. Materials -- 2.1. Common disposables -- 2.2. Cells and reagents -- 2.3. Equipment -- 3. Methods -- 3.1. Cell culture and treatments (see Note 9) -- 3.2. RNA extraction (see Note 19) -- 3.3. RT-PCR (see Note 32) -- 3.4. Data analysis -- 4. Notes -- 5. Concluding remarks -- Acknowledgments -- Competing interests -- References -- Chapter 11: ELISA-based quantification of type I IFN secretion by irradiated cancer cells -- 1. Introduction -- 2. Material -- 2.1. Disposables -- 2.2. Cells and reagents -- 2.3. Equipment -- 2.4. Software -- 3. Method -- 3.1. Cell culture, treatment and sample collection -- 3.2. Enzyme-linked immunosorbent assay (ELISA) -- 3.2.1. Reagent preparation -- 3.2.2. Procedure -- 3.2.3. Data analysis -- 3.3. Bead-based multiplex immunoassays -- 3.3.1. Reagent preparation -- 3.3.2. Procedure -- 3.3.3. Data acquisition with a flow cytometer and analysis -- 4. Concluding remarks -- Conflict of interest statement -- References -- Chapter 12: Assessment of hypoxia by pimonidazole staining following radiotherapy -- 1. Introduction -- 1.1. Hypoxia in tumors -- 1.2. Methods to measure hypoxia -- 1.3. Pimonidazole HCl -- 2. Materials -- 2.1. Common disposables -- 2.2. Equipment -- 2.3. Reagents -- 3. Methods -- 3.1. Establishment of B16F10 melanoma tumors and radiotherapy treatment
3.2. Pimonidazole administration, tumor collection and OCT preservation -- 3.3. Pimonidazole staining and fluorescence microscopy -- 4. Notes -- 5. Concluding remarks -- Disclosures -- References
鏈接 Original 0323899498 9780323899499 (OCoLC)1331705957
Print version: Radiation oncology and radiotherapy. Part A. 9780323899499 (OCoLC)1338669357
主題 Radiotherapy -- Technological innovations
Cancer -- Radiotherapy -- Technological innovations
Radiotherapy
Radiation Oncology
Electronic books
Alt Author Sato, Ai, editor
Record:   Prev Next